114 related articles for article (PubMed ID: 6737077)
1. Tc-99m galactosyl-neoglycoalbumin: in vitro characterization of receptor-mediated binding.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
J Nucl Med; 1984 Jul; 25(7):779-87. PubMed ID: 6737077
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m galactosyl-neoglycoalbumin: preparation and preclinical studies.
Vera DR; Stadalnik RC; Krohn KA
J Nucl Med; 1985 Oct; 26(10):1157-67. PubMed ID: 4045560
[TBL] [Abstract][Full Text] [Related]
3. Kinetic sensitivity of a receptor-binding radiopharmaceutical: technetium-99m galactosyl-neoglycoalbumin.
Vera DR; Woodle ES; Stadalnik RC
J Nucl Med; 1989 Sep; 30(9):1519-30. PubMed ID: 2549225
[TBL] [Abstract][Full Text] [Related]
4. Measurement of receptor concentration and forward-binding rate constant via radiopharmacokinetic modeling of technetium-99m-galactosyl-neoglycoalbumin.
Vera DR; Stadalnik RC; Trudeau WL; Scheibe PO; Krohn KA
J Nucl Med; 1991 Jun; 32(6):1169-76. PubMed ID: 2045930
[TBL] [Abstract][Full Text] [Related]
5. Gallium-labeled deferoxamine-galactosyl-neoglycoalbumin: a radiopharmaceutical for regional measurement of hepatic receptor biochemistry.
Vera DR
J Nucl Med; 1992 Jun; 33(6):1160-6. PubMed ID: 1597732
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of (99m)Tc-DMP-NGA as a novel hepatic asialoglycoprotein receptor imaging agent.
Yang W; Mou T; Zhang X; Wang X
Appl Radiat Isot; 2010 Jan; 68(1):105-9. PubMed ID: 19815422
[TBL] [Abstract][Full Text] [Related]
7. Validation of in vivo receptor measurements via in vitro radioassay: technetium-99m-galactosyl-neoglycoalbumin as prototype model.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
J Nucl Med; 1991 Jun; 32(6):1177-82. PubMed ID: 2045931
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m-galactosyl-neoglycoalbumin: in vivo characterization of receptor-mediated binding to hepatocytes.
Vera DR; Krohn KA; Stadalnik RC; Scheibe PO
Radiology; 1984 Apr; 151(1):191-6. PubMed ID: 6701314
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-neoglycoalbumin (NGA)-binding to human hepatic binding protein (HBP) in vitro.
Virgolini I; Angelberger P; Müller C; O'Grady J; Sinzinger H
Br J Clin Pharmacol; 1990 Feb; 29(2):207-14. PubMed ID: 2306412
[TBL] [Abstract][Full Text] [Related]
10. [Galactosyl neoglycoalbumin:preparation and studies of its binding with hepatic special receptor].
Pang Q; Yang L; Zhong Y; Guan C; Zhao Q; Tan T
Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(4):368-71. PubMed ID: 1814813
[TBL] [Abstract][Full Text] [Related]
11. Quantification of human hepatic binding protein (HBP) via 99mTc-galactosyl-neoglycoalbumin (NGA) liver scintigraphy.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Wien Klin Wochenschr; 1991; 103(15):458-61. PubMed ID: 1926872
[TBL] [Abstract][Full Text] [Related]
12. In vivo estimates of hepatic binding protein concentration: correlation with classical indicators of hepatic functional reserve.
Kudo M; Vera DR; Stadalnik RC; Trudeau WL; Ikekubo K; Todo A
Am J Gastroenterol; 1990 Sep; 85(9):1142-8. PubMed ID: 2389727
[TBL] [Abstract][Full Text] [Related]
13. Functional liver imaging with 99Tcm-galactosyl-neoglycoalbumin (NGA) in alcoholic liver cirrhosis and liver fibrosis.
Virgolini I; Müller C; Angelberger P; Höbart J; Bergmann H; Sinzinger H
Nucl Med Commun; 1991 Jun; 12(6):507-17. PubMed ID: 1866104
[TBL] [Abstract][Full Text] [Related]
14. Tc-NGA imaging in liver transplantation: preclinical studies.
Woodle ES; Vera DR; Stadalnik RC; Ward RE
Surgery; 1987 Jul; 102(1):55-62. PubMed ID: 3296267
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m NGA functional hepatic imaging: preliminary clinical experience.
Stadalnik RC; Vera DR; Woodle ES; Trudeau WL; Porter BA; Ward RE; Krohn KA; O'Grady LF
J Nucl Med; 1985 Nov; 26(11):1233-42. PubMed ID: 2997417
[TBL] [Abstract][Full Text] [Related]
16. Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
Virgolini I; Müller C; Klepetko W; Angelberger P; Bergmann H; O'Grady J; Sinzinger H
Br J Cancer; 1990 Jun; 61(6):937-41. PubMed ID: 2164838
[TBL] [Abstract][Full Text] [Related]
17. Hepatic uptake of [99mTc]galactosyl-neoglycoalbumin is sensitive to receptor quantity.
Kudo M; Vera DR; Trudeau WL; Stadalnik RC
Int J Rad Appl Instrum B; 1991; 18(7):663-6. PubMed ID: 1787074
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-galactosyl-neoglycoalbumin combined with iodine-123-Tyr-(A14)-insulin visualizes human hepatocellular carcinomas.
Kurtaran A; Li SR; Raderer M; Leimer M; Müller C; Pidlich J; Neuhold N; Hübsch P; Angelberger P; Scheithauer W
J Nucl Med; 1995 Oct; 36(10):1875-81. PubMed ID: 7562058
[TBL] [Abstract][Full Text] [Related]
19. Differences in the intracellular processing of the radiolabel following the uptake of iodine-125- and technetium-99m-neogalactosyl albumin by the isolated perfused rat liver.
Gore S; Morris AI; Gilmore IT; Maltby PJ; Thornback JR; Billington D
J Nucl Med; 1991 Mar; 32(3):506-11. PubMed ID: 2005461
[TBL] [Abstract][Full Text] [Related]
20. Identifiability analysis of an in vivo receptor-binding radiopharmacokinetic system.
Vera DR; Krohn KA; Scheibe PO; Stadalnik RC
IEEE Trans Biomed Eng; 1985 May; 32(5):312-22. PubMed ID: 3997184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
